Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2007
11/21/2007CN100349573C Formulation for lipophilic agents
11/21/2007CN100349567C (-)-epigallocatechin gallate-magnesium complex solid dispersion and its prepn and application
11/20/2007US7297818 Adamantane derivatives
11/20/2007US7297808 Statin derivatives
11/20/2007US7297792 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
11/20/2007US7297763 Mixture of IGF-1 and N,N-bis(3-D-gluconamidopropyl)-deoxycholamine that binds specifically to IGF-1 and blocks binding of IGFBP-1 and IGFBP-3; used as a standard for identifying IGF-1 indirect agonists
11/20/2007US7297761 Pharmaceutical compositions containing exendins
11/20/2007US7297715 PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
11/20/2007US7297708 Central nervous system disorders; psychological disorders
11/20/2007US7297707 Selective CB1 G protein coupled receptor antagonists; obesity; such as N-benzothiazol-2-yl-2-chloro-N-(3,4-dimethoxy-phenyl)-4-fluoro-benzamide
11/20/2007US7297696 Antiarthritic agents; antihistamines; atherosclerosis; multiple sclerosis; Crohn's disease; nephritis; pancreastitis; skin disorders; restenosis; prevent leukocyte migration
11/20/2007US7297692 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
11/20/2007US7297681 For use in therapy of growth metabolic disorders
11/20/2007US7297523 Human elongase genes and uses thereof
11/20/2007US7297099 Use of osteopontin for the treatment and/or prevention of neurologic diseases
11/20/2007CA2429642C Fused heteroaromatic glucokinase activators
11/20/2007CA2295746C Composition comprising l-carnitine or an alkanoyl l-carnitine and long-chain alkanols
11/20/2007CA2206362C Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
11/20/2007CA2140382C Vitamin d compounds and method of preparing these compounds
11/17/2007CA2587319A1 Cmklr regulation of adipogenesis and adipocyte metabolic function
11/16/2007CA2554386A1 Combinations of hmg coa reductase inhibitors and negatively charged phospholipids and uses thereof
11/15/2007WO2007130075A1 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
11/15/2007WO2007129743A1 Anti-inflammatory composition
11/15/2007WO2007129668A1 Pyrazolyl 5-thioglucoside compound
11/15/2007WO2007129618A1 Inhibitor of neutrophil activation/migration factor and use thereof
11/15/2007WO2007129522A1 Preparation produced by dry process
11/15/2007WO2007129473A1 Bicyclic aryl derivative
11/15/2007WO2007129439A1 Inhibitor of increase in postprandial blood insulin level
11/15/2007WO2007129048A1 Thiazole derivatives as inhibitors of p13 kinase
11/15/2007WO2007129005A1 Aminoacid derivatives of thiazoles as inhibitors of pi3 kinase
11/15/2007WO2007128901A1 Use of alpha-lactalbumin for regulation of glycemia
11/15/2007WO2007128801A1 Combination of organic compounds
11/15/2007WO2007128761A2 Uses of dpp-iv inhibitors
11/15/2007WO2007128724A1 Dpp iv inhibitor formulations
11/15/2007WO2007128721A1 Polymorphs
11/15/2007WO2007128480A2 Thioglycosides as pharmaceutically active agents
11/15/2007WO2007128465A1 Xanthone derivative for the treatment of muscular disorders
11/15/2007WO2007128442A1 Use of an antipsychotic drug for the treatment of als-associated cachexia
11/15/2007WO2007128121A1 Chimeric pcsk9 proteins, cells comprising same, and assays using same
11/15/2007WO2007109088A3 Combinationtherapies of thiazolidinedione analogues and glucocorticoid agonists
11/15/2007WO2007109024A3 Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease
11/15/2007WO2007108744A3 Novel quinazolines as 5-ht6 modulators
11/15/2007WO2007108743A3 Novel quinazolines as 5-ht6 modulators ii
11/15/2007WO2007104867A3 Cosmetic, pharmaceutical, food and veterinary compositions whose activating action on genes of sirtuin type makes it possible to delay ageing in mammals and the harmful effects thereof
11/15/2007WO2007096753A3 Process for preparing highly pure simvastatin
11/15/2007WO2007084591A3 Novel solid forms of (4r)-1-[4-(2-chloro-5-fluorobenzoyl)amino-3-methoxybenzoyl]-1,2,3,5-tetrahydro-spiro[4h-1-benzazepine-4,1'-[2]cyclopentene]-3'-carboxylic acid
11/15/2007WO2007076379A3 4,7-dihydrothieno[2,3-b]pyridine compounds and pharmaceutical compositions
11/15/2007WO2007067615A3 Thiadiazole derivatives as antidiabetic agents
11/15/2007WO2006086456A3 Combination of organic compounds
11/15/2007WO2002019842A3 Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof
11/15/2007US20070265449 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
11/15/2007US20070265349 Medicinal association of a biguanine and a carrier, for example metformin and arginine
11/15/2007US20070265334 Method for treating amyloidosis
11/15/2007US20070265323 Compounds for the treatment of metabolic disorders
11/15/2007US20070265322 Compounds for the treatment of metabolic disorders
11/15/2007US20070265320 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity
11/15/2007US20070265319 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases
11/15/2007US20070265302 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
11/15/2007US20070265301 Dpp-IV Inhibitors
11/15/2007US20070265299 Compounds for the treatment of inflammatory disorders
11/15/2007US20070265297 Thiazolopyridine Derivatives, Pharmaceut Ical Conditions Containing Them And Methods Of Treating Glucokinase Mediated Conditions
11/15/2007US20070265296 Nuclear receptor binding agents
11/15/2007US20070265286 Quinazoline derivatives as VEGF inhibitors
11/15/2007US20070265284 Substituted 8-aminoalkylthioxanthines, and their use as inhibitors of dipeptidyl peptidase iv
11/15/2007US20070265283 Xanthine Oxidase Inhibitor
11/15/2007US20070265273 Pyrimidin-2-Amine Derivatives and Their Use as A2b Adenosine Receptor Antagonists
11/15/2007US20070265271 (8-Methyl-3,8-diaza-bicyclo[3.2.1]oct-3-yl)-[5-(4-nitro-phenyl)-furan-2-yl]-methanone; cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; nervous system diseases; inflammation, pain; drug addiction
11/15/2007US20070265270 Cinnoline derivatives as phosphodiesterase 10 inhibitors
11/15/2007US20070265263 Heterocyclic inhibitors of ERK2 and uses thereof
11/15/2007US20070265261 Dpp-IV Inhibitors
11/15/2007US20070265248 Substituted piperazines and methods of use
11/15/2007US20070265216 Enhanced medical treatment in diabetic cardiomyopathy
11/15/2007US20070265201 Inhibitors of inflammatory cytokine transcription derived from hcmv protein ie2
11/15/2007US20070265200 Glycol Linked Fgf-21 Compounds
11/15/2007US20070265192 Telechelic Homopolyamino Acids Functionalized with Hydrophobic Groups, and Their Applications, Especially Therapeutic Applications
11/15/2007US20070265189 Insulin and igf-1 receptor agonists and antagonists
11/15/2007US20070265188 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
11/15/2007US20070264417 Procyanidins; cleaning cocoa beans, heating unroasted cocoa nibs to loosen shells, winnowing the nibs from the shells, extracting with a polar solvent, a non-polar solvent, or a supercritical fluid
11/15/2007US20070264371 Product of coromandel and method for its use
11/15/2007US20070264347 Agent for Treating or Preventing Diabetic Neuropathy
11/15/2007US20070264334 Modified release formulation of fenofibric acid in a hydroxypropyl methylcellulose matrix; in vitro dissolution is substantially independent of the dissolution media ionic strength
11/15/2007US20070264331 Stable pharmaceutical composition of immediate-release glimepiride and extended-release metformin
11/15/2007US20070264249 Gene-based lipid hydrolysis therapy for atherosclerosis and related diseases
11/15/2007US20070264246 ENHANCED MEDICAL TREATMENTS RESULTING FROM CHEMICAL IDENTIFICATION OF CALCIUM INFLUX FACTOR, IDENTITY WITH THE FACTOR ACTIVATING PHOSPHOLIPOLYSIS AND PRECIPITATING SUDDEN DEATH DURING MYOCARDIAL INFARCTION, AND DETERMINATION OF SIMILAR ACTIVATING MECHANISMS IN MULTIPLE CELL TYPES THROUGH DISINHIBITION OF CALCIUM-INDEPENDENT PHOSPHOLIPASE A2beta
11/15/2007US20070264194 Peptides That Bind To Atherosclerotic Lesions
11/15/2007DE102006021878A1 Phenylamino-benzoxazol substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Phenylamino-benzoxazole substituted carboxylic acids, process for their preparation and their use as medicaments
11/15/2007CA2652247A1 Chimeric pcsk9 proteins, cells comprising same, and assays using same
11/15/2007CA2651089A1 Polymorphs
11/15/2007CA2651019A1 Uses of dpp iv inhibitors
11/15/2007CA2650495A1 Use of alpha-lactalbumin for regulation of glycemia
11/15/2007CA2649922A1 Dpp iv inhibitor formulations
11/15/2007CA2618646A1 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
11/14/2007EP1854880A1 Methods and reagents for modulating cholesterol levels
11/14/2007EP1854795A1 Salt of proline derivative, solvate thereof, and production method thereof
11/14/2007EP1854794A1 2-N-{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2-4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
11/14/2007EP1854784A1 Activator for peroxisome proliferator activating receptor
11/14/2007EP1854777A1 Hydroquinone long-chain derivative and/or phenoxy long-chain derivative, and pharmaceutical preparation comprising the same
11/14/2007EP1854483A1 Agent for control of function of antigen-presenting cell
11/14/2007EP1854482A1 Agent for control of degranulation reaction and cytokine production
11/14/2007EP1854475A1 Use of leptin for the prevention of excess body weight and composition containing leptin
1 ... 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 ... 1298